NAT2 slow acetylation and GSTM1 null genotypes increase bladder cancer risk: results from the Spanish Bladder Cancer Study and meta-analyses

Background: Many associations between common genetic polymorphisms and complex diseases have not been replicated. One of the few exceptions may be the association between NAT2 slow acetylation, GSTM1 null genotype and bladder cancer risk. However, current evidence is based on meta-analyses of relati...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: García-Closas, Montserrat, Malats, Núria, Silverman, Debra, Dosemeci, Mustafa, Kogevinas, Manolis, Hein, David W., Tardón, Adonina, Serra, Consol, Carrato, Alfredo, García-Closas, Reina, Lloreta, Josep, Castaño-Vinyals, Gemma, Yeager, Meredith, Welch, Robert, Chanock, Stephen, Chatterjee, Nilanjan, Wacholder, Sholom, Samanic, Claudine, Torà, Montserrat, Fernández, Francisco, Real, Francisco X., Rothman, Nathaniel
פורמט: Artigo
שפה:Inglês
יצא לאור: 2005
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1459966/
https://ncbi.nlm.nih.gov/pubmed/16112301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(05)67137-1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים